Top Markets
Coin of the day
DiaSorin S.p.A. DiaSorin S.p.A.

DiaSorin S.p.A.

DIA
Clasificación en acciones #3944
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Precio por acción
$89.74
Capitalización bursátil
$4.44B
Cambio (1 día)
-0.39%
Cambio (1 año)
-14.79%
País
IT
Comercio DiaSorin S.p.A. (DIA)

Categoría

Ratio P/B de DiaSorin S.p.A. (DIA)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de DiaSorin S.p.A., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de DiaSorin S.p.A. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US